Tawazun Health
  • Home
  • Corporate
  • Health Screening
  • Public Health
  • Individual
  • About
  • Louise Campbell
  • News
  • Contact
Select Page
tawazun logo

News

Fatty Liver Alliance’s Video with Louise Campbell

Jun 12, 2024

read more

S5 – E18 – Introducing HOPE: A Support Program for Patients Living with the Effects of ALD and Cirrhosis

Jun 6, 2024

Guided VCTE: A New Era in Liver Health Diagnostics

May 27, 2024

Why You Might Need A Fibroscan: Exploring Its Importance In Liver Health

Why You Might Need A Fibroscan: Exploring Its Importance In Liver Health

Mar 18, 2024

Why you should have a Fibroscan® Screening In the corporate world, where occupational health is becoming more and more important, understanding the...

read more
The Somerset NHS FT’s Revolutionary Identification System for Liver Disease

The Somerset NHS FT’s Revolutionary Identification System for Liver Disease

Jan 15, 2024

In an era marked by astonishing technological advancements, the healthcare sector stands at the forefront of innovation, continually striving to...

read more
Exploring Louise Campbell’s Expertise and Tawazun Health’s Impact on FibroScan

Exploring Louise Campbell’s Expertise and Tawazun Health’s Impact on FibroScan

Jan 11, 2024

In the dynamic realm of medical science, breakthroughs are driven by the convergence of expertise and innovative partnerships. A shining example of...

read more
Read this interview in Belgravia London, with Louise Campbell, founder and clinical director of Tawazun Health.

Read this interview in Belgravia London, with Louise Campbell, founder and clinical director of Tawazun Health.

Jan 4, 2024

Louise Campbell is the founder and Clinical Director of Tawazun Health; with over 40 years experience working in the healthcare industry in the UK...

read more

S3-E41.1 – Improving NASH Clinical Trials By Reducing Screen Fail Rates

Aug 20, 2022

S3-E41- Improving NASH Clinical Trials By Reducing Screen Fail Rates

Aug 20, 2022

Improving NASH Clinical Trials By Reducing Screen Fail Rates

Aug 18, 2022

S3-E40.5 – From the Vault: Why Cirrhosis Matters In Clinical Trial Strategy

Aug 15, 2022

S3-E40.4 – Challenges of Alcohol Screening in Fatty Liver Disease

Aug 14, 2022

« Older Entries
Next Entries »

Tawazun Health HQ
23 Harley Street
London W1G 9QN

T +44 (0)20 7788 8452
E health@tawazunhealth.com

Ce Square V3 2025 (1)   Care quality commission

App Store & Podcast

Mylife365 Mash

NAVIGATE

  • Corporate
  • Health Screening
  • Public Health
  • Individuals
  • About
  • News
  • Sources
  • Bookings
December 3, 2025
Louise Campbell to Present at the First European Primary Care MASLD/MASH Summit 2025
July 1, 2025
Tawazun Health Shares Global Insights from EASL 2025
June 3, 2025
Tawazun Health and LiverScan Group Announce Strategic Partnership to Expand High-Quality FibroScan® Services Across the UK
© TAWAZUN HEALTH 2023  | Website created by Fisher Digital | Terms & Conditions | Privacy Policy | Disclaimer
  • Follow
  • Follow
  • Follow
  • Follow
Call Now
Enquire Now